Literature DB >> 36261597

Feasibility of autologous peripheral blood stem cell mobilization and harvest in adult patients with FLT3-mutated acute myeloid leukemia receiving chemotherapy combined with midostaurin: a single-center experience.

Stefano Cordella1, Angelica Parisotto1, Francesca Bettelli1, Monica Morselli1, Emiliano Barbieri1, Stefano Pozzi1, Anna Aquilino1, Gianluca Repaci1, Angela Cuoghi1, Paola Bresciani1, Andrea Messerotti1, Corrado Colasante1, Andrea Gilioli1, Valeria Pioli1, Davide Giusti1, Elisabetta Colaci1, Luca Cassanelli1, Giovanni Ceccherelli2, Mirco Bevini2, Roberta Malavolti2, Donatella Venturelli2, Ambra Paolini1, Silvia Martinelli1, Rossana Maffei1, Giovanni Riva3, Vincenzo Nasillo3, Tommaso Trenti3, Patrizia Comoli4, Enrico Tagliafico5, Rossella Manfredini6, Patrizia Barozzi1, Leonardo Potenza1, Roberto Marasca1, Mario Luppi7, Fabio Forghieri8.   

Abstract

Entities:  

Year:  2022        PMID： 36261597     DOI： 10.1007/s00277-022-05013-4

Source DB:  PubMed          Journal:  Ann Hematol        ISSN： 0939-5555            Impact factor:   4.030


× No keyword cloud information.
  8 in total

1.  The storage and re-infusion of autologous blood and BM as back-up following failed primary hematopoietic stem-cell transplantation: a survey of European practice.

Authors:  B Pottinger; M Walker; M Campbell; T L Holyoake; I M Franklin; G Cook
Journal:  Cytotherapy       Date:  2002       Impact factor: 5.414

2.  GIMEMA AML1310 trial of risk-adapted, MRD-directed therapy for young adults with newly diagnosed acute myeloid leukemia.

Authors:  Adriano Venditti; Alfonso Piciocchi; Anna Candoni; Lorella Melillo; Valeria Calafiore; Roberto Cairoli; Paolo de Fabritiis; Gabriella Storti; Prassede Salutari; Francesco Lanza; Giovanni Martinelli; Mario Luppi; Patrizio Mazza; Maria Paola Martelli; Antonio Cuneo; Francesco Albano; Francesco Fabbiano; Agostino Tafuri; Anna Chierichini; Alessia Tieghi; Nicola Stefano Fracchiolla; Debora Capelli; Robin Foà; Caterina Alati; Edoardo La Sala; Paola Fazi; Marco Vignetti; Luca Maurillo; Francesco Buccisano; Maria Ilaria Del Principe; Maria Irno-Consalvo; Tiziana Ottone; Serena Lavorgna; Maria Teresa Voso; Francesco Lo-Coco; William Arcese; Sergio Amadori
Journal:  Blood       Date:  2019-08-08       Impact factor: 22.113

3.  Presence of FLT3 mutations does not impair stem cell mobilization and feasibility of autologous peripheral blood stem cell transplantation in acute myeloid leukemia.

Authors:  Felicetto Ferrara; Salvatore Palmieri; Filiberto Pollio; Catia Lo Pardo; Daniela Graziano; Maria Celentano; Maria Rosaria D'Amico; Laura Vicari; Barbara Izzo; Fabrizio Pane
Journal:  Biol Blood Marrow Transplant       Date:  2006-09       Impact factor: 5.742

4.  Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation.

Authors:  Richard M Stone; Sumithra J Mandrekar; Ben L Sanford; Kristina Laumann; Susan Geyer; Clara D Bloomfield; Christian Thiede; Thomas W Prior; Konstanze Döhner; Guido Marcucci; Francesco Lo-Coco; Rebecca B Klisovic; Andrew Wei; Jorge Sierra; Miguel A Sanz; Joseph M Brandwein; Theo de Witte; Dietger Niederwieser; Frederick R Appelbaum; Bruno C Medeiros; Martin S Tallman; Jürgen Krauter; Richard F Schlenk; Arnold Ganser; Hubert Serve; Gerhard Ehninger; Sergio Amadori; Richard A Larson; Hartmut Döhner
Journal:  N Engl J Med       Date:  2017-06-23       Impact factor: 91.245

5.  Are backup BM harvests worthwhile in unrelated donor allogeneic transplants?

Authors:  C Stotler; B Bolwell; R Sobecks; R Dean; S Serafino; L Rybicki; S Andresen; B Pohlman; M Kalaycio; E Copelan
Journal:  Bone Marrow Transplant       Date:  2009-05-04       Impact factor: 5.483

6.  Impact of NPM1/FLT3-ITD genotypes defined by the 2017 European LeukemiaNet in patients with acute myeloid leukemia.

Authors:  Konstanze Döhner; Christian Thiede; Nikolaus Jahn; Ekaterina Panina; Agnes Gambietz; Richard A Larson; Thomas W Prior; Guido Marcucci; Dan Jones; Jürgen Krauter; Michael Heuser; Maria Teresa Voso; Tiziana Ottone; Josep F Nomdedeu; Sumithra J Mandrekar; Rebecca B Klisovic; Andrew H Wei; Jorge Sierra; Miguel A Sanz; Joseph M Brandwein; Theo de Witte; Joop H Jansen; Dietger Niederwieser; Frederick R Appelbaum; Bruno C Medeiros; Martin S Tallman; Richard F Schlenk; Arnold Ganser; Hubert Serve; Gerhard Ehninger; Sergio Amadori; Insa Gathmann; Axel Benner; Celine Pallaud; Richard M Stone; Hartmut Döhner; Clara D Bloomfield
Journal:  Blood       Date:  2020-01-30       Impact factor: 22.113

Review 7.  Clinical practice recommendation on hematopoietic stem cell transplantation for acute myeloid leukemia patients with FLT3-internal tandem duplication: a position statement from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.

Authors:  Ali Bazarbachi; Gesine Bug; Frederic Baron; Eolia Brissot; Fabio Ciceri; Iman Abou Dalle; Hartmut Döhner; Jordi Esteve; Yngvar Floisand; Sebastian Giebel; Maria Gilleece; Norbert-Claude Gorin; Elias Jabbour; Mahmoud Aljurf; Hagop Kantarjian; Mohamed Kharfan-Dabaja; Myriam Labopin; Francesco Lanza; Florent Malard; Zinaida Peric; Thomas Prebet; Farhad Ravandi; Annalisa Ruggeri; Jaime Sanz; Christoph Schmid; Roni Shouval; Alexandros Spyridonidis; Jurjen Versluis; Norbert Vey; Bipin N Savani; Arnon Nagler; Mohamad Mohty
Journal:  Haematologica       Date:  2020-04-02       Impact factor: 9.941

Review 8.  FLT3 mutated acute myeloid leukemia: 2021 treatment algorithm.

Authors:  Naval Daver; Sangeetha Venugopal; Farhad Ravandi
Journal:  Blood Cancer J       Date:  2021-05-27       Impact factor: 11.037
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.